Ahmad OS,Morris JA,Mujammami M,Forgetta V,Leong A,Li R,Turgeon M,Greenwood CM,Thanassoulis G,Meigs JB .2015 .A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat. Commun, 6(1) : 1-11.
Auwal F,Dahiru MN,Abdu-Aguye SN,Pract SN .2019 .Availability and rationality of fixed dose combinations available in Kaduna, Nigeria. , 17(2) : 1-5.
Azqueta A,Collins AR .2013 .The essential comet assay: A comprehensive guide to measuring DNA damage and repair. Arch, 87(6) : 949-968.
Błaszczyk B,Miziak B,Czuczwar P,WierzchowskaCioch E,Pluta R,Czuczwar SJ .2018 .A viewpoint on rational and irrational fixed-drug combinations. Expert Rev. Clin. Pharmacol, 11(8) : 761-71.
Colhoun HM,Betteridge DJ,Durrington PN,Hitman GA,Neil Haw,Livingstone SJ,Thomason MJ,Mackness MI,Charlton-Menys V,Fuller JH .2004 .Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): Multicentre randomised placebo-controlled trial. The Lancet., 364(9435) : 685-696.
Damrot J,Nübel T,Epe B,Roos W,Kaina B,Fritz G .2006 .Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Br. J. Pharmacol., 149(8) : 988-997.
De Sousa JA,Pereira P,Da Costa Allgayer M,Marroni NP .2017 .Evaluation of DNA damage in Wistar rat tissues with hyperlipidemia induced by tyloxapol. Exp. Mol. Pathol, 103(1) : 51-55.
Donmez-Altuntas H,Bayram F,Coskun-Demirkalp AN,Baspınar O,Kocer D,Toth PP D .2019 .Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients. Exp Biol Med, 244(13) : 1089-1095.
Rakhmanina N Dubrocq G .2018 .The pharmacokinetics, pharmacodynamics and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection. Expert Opin Drug Met, 14(8) : 773-9.
Franzoni F,Quiñones-Galvan A,Regoli F,Ferrannini E,Galetta F E .2003 .A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol., 90(2-3) : 317-321.
Girona J,La Ville AE,Solà R,Plana N,Masana LS .1999 .Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am. J. Card., 83(6) : 846-851.
Godman B,McCabe H,D Leong T,Mueller D,Martin AP,Hoxha I .2020 .Fixed dose drug combinations are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries. Expert Rev Pharm Out, 20(1) : 1-26.
Gul OO,Cinkilic N,Gul CB,Cander S,Vatan O,Ersoy C,Yılmaz D,Tuncel E .2013 .Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: A cross-sectional, observational pilot study. Mutat Res-Gen Tox En., 757(1) : 31-35.
Gupta R,Malhotra A,Malhotra P .2018 .Assessment of rational use of fixed dose combinations in hypertension in a tertiary care teaching hospital in north India. Int. J. Adv. Med, 5(5) : 1263-1267.
Inzucchi SE,Bergenstal RM,Buse JB,Diamant M,Ferrannini E,Nauck M,Peters AL,Tsapas A,Wender R,Matthews DR .2015 .Management of hyperglycemia in type 2 diabetes, 2015: A patientcentered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. , 38(1) : 140-149.
Menditto E,Orlando V,De Rosa G,Minghetti P,Musazzi UM,Cahir C .2020 .Patient centric pharmaceutical drug product design. The impact on medication adherence. , 12(1) : 44.
Pedersen TR,Tobert JA .2004 .Simvastatin: A review. Expert Opin Pharmaco. , 5(12) : 2583-2596.
Ramadan WH,Kabbara WK .2015 .Sitagliptin/Simvastatin: A first combination tablet to treat type 2 diabetes and hypercholesterolemia a review of its characteristics. Vasc Health Risk Manag., 11 : 125.
Ramesh B,Manjula N,Bijargi S,Sarma V,Devi PS .2015 .Comparison of conventional and supported liquid extraction methods for the determination of sitagliptin and simvastatin in rat plasma by LC-ESIMS/MS. , 5(3) : 161-168.
Seidl K,Zinkernagel AS K .2013 .The MTT assay is a rapid and reliable quantitative method to assess Staphylococcus aureus induced endothelial cell damage. J. Microbiol. Methods., 92(3) : 307-309.
Sharif A,Akhtar MF,Akhtar B,Saleem A,Manan M,Shabbir M,Ashraf M,Peerzada S,Ahmed S,Raza M .2017 .Genotoxic and cytotoxic potential of whole plant extracts of Kalanchoe laciniata by Ames and MTT assay. , 16(1) : 593.
Sharif A,Ashraf M,Anjum AA,Javeed A,Altaf I,Akhtar MF,Abbas M,Akhtar B,Saleem A .2016 .Pharmaceutical wastewater being composite mixture of environmental pollutants may be associated with mutagenicity and genotoxicity. Environ. Sci. Pollut, 23(3) : 2813-2820.
Singh NP,Mccoy MT,Tice RR,Schneider EL .1988 .A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res, 175(1) : 184-191.
Ylvester PW .2011 .Drug Design and Discovery. Methods in Molecular Biology (Methods and Protocols), 175(1) : 184-191.
Yuzbasioglu D,Enguzel-Alperen C,Unal F C .2018 .Investigation of in vitro genotoxic effects of an antidiabetic drug sitagliptin. Food Chem, 112(1) : 235-241.
Zonoozi S,Barnard M,Prescott E,Jones R,Shah FT,Tzoulis P .2017 .Effectiveness and safety of sitagliptin in patients with beta-thalassaemia major and diabetes mellitus: A case series. Mediterr. J. Hematol. Infect Dis, 9(1) : e2017004.